Navigation Links
Elsevier's Biochimica et Biophysica Acta (BBA) journal series adds open access journal: BBA Clinical
Date:11/13/2013

Oxford, November 13, 2013, - Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces the launch of BBA Clinical, the first full open access journal within the Biochimica et Biophysica Acta (BBA) journal series. BBA Clinical will focus on translating molecular insights into clinical research.

BBA Clinical is a biomedical journal dedicated to publishing research on the molecular basis of human diseases, as well as presenting findings from clinical trials that target biochemical pathways and processes. All articles in BBA Clinical describe, in part or entirely, studies using human patient samples or human cohorts. Clinical areas of particular interest include aging, cancer, cardiovascular-, metabolic-, neurological-, and immunological diseases; the interactions that may occur among these different diseases and conditions; and studies that examine their early or pre-symptomatic states. Cross-sectional and prospective studies from well-established cohorts, and studies involving imaging methodologies, are particularly encouraged for submission.

"The journal provides a new forum for insights concerning the biochemical mechanisms related to diagnosis, progression, and treatment of a wide range of human diseases," said BBA Clinical Executive Editor, Jeffrey N. Keller from Pennington Biomedical Research Center, Baton Rouge, Louisiana. "BBA Clinical will offer not just a useful forum for clinical research today, but it is designed to be a prominent contributor to the larger overall body of clinical advancements far into the future."

"We are very excited about the launch of BBA Clinical," added Dolors Alsina, Executive Publisher at Elsevier. "The journal will build on our long standing track record as one of the leading international journals focusing on molecular aspects in biology and medicine and will break new ground as the clinical complement to BBA Molecular Basis of Disease."


'/>"/>

Contact: Kristian Wilson
k.wilson@elsevier.com
44-186-584-3817
Elsevier
Source:Eurekalert

Related biology news :

1. Media invited: Biophysical Society Annual Meeting
2. Biophysical Society announces 2013 New and Notable Symposium speakers
3. Biophysical Society announces winners of 2013 international travel awards
4. Biophysical Society announces winners of 2013 Education Committee travel awards
5. Biophysical Society announces winners of 2013 CPOW travel awards
6. Biophysical Society names 2013 Distinguished Service, Emily M. Gray, and Founders awardees
7. Biophysical Society names 5 2013 award recipients
8. Elsevier launches new open access journal: Photoacoustics
9. Winners named in 2013 AAAS Kavli Science Journalism Awards competition
10. Frontiers launches 2 new open-access journals: Frontiers in Earth Science and Frontiers in Environmental Science
11. Frontiers launches a new open-access journal in Cell and Developmental Biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... 2016   The Weather Company , an IBM Business ... industry-first capability in which consumers will be able to interact ... questions via voice or text and receive relevant information about ... Marketers have long sought an advertising solution that can ... personal, relevant and valuable; and can scale across millions of ...
(Date:5/24/2016)... Calif. , May 24, 2016 Ampronix facilitates superior patient care by ... LMD3251MT  3D medical LCD display is the latest premium product recently added to the ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):
(Date:6/24/2016)...  Regular discussions on a range of subjects including policies, ... entities said Poloz. Speaking at a lecture to ... he pointed to the country,s inflation target, which is set ... "In certain areas there needs ... economic goals, why not sit down and address strategy together?" ...
(Date:6/24/2016)... , ... June 24, 2016 , ... While the majority ... as the Cary 5000 and the 6000i models are higher end machines that use ... height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
Breaking Biology Technology: